Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | CTRC | Q99895 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.41 |
| ▸ | ACP3 | P15309 | 1/20 | 0.41 |
| ▸ | IDH1 | O75874 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28812727 | 0.75 | MAOA (0.53) | MAOAMAOBALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL2516397 | 0.74 | ACP3 (0.42) | CTRCALDH1A1TDP1CYP1A2CYP2C19 | |
| SCHEMBL6061351 | 0.73 | MAOA (0.59) | MAOAMAOBKMT2A | |
| SCHEMBL599659 | 0.73 | CYP2C19 (0.62) | CTRCALDH1A1TDP1CYP1A2CYP2C19 | |
| SCHEMBL29490353 | 0.73 | CYP2C19 (0.62) | CTRCALDH1A1TDP1CYP1A2CYP2C19 | |
| SCHEMBL1079030 | 0.73 | ALDH1A1 (0.46) | MAOAMAOBALDH1A1TDP1CYP1A2 | |
| SCHEMBL10896758 | 0.73 | MAOA (0.58) | MAOAMAOBALDH1A1TDP1CYP1A2 | |
| SCHEMBL27093593 | 0.72 | MAOA (0.53) | MAOAMAOBALDH1A1MAPTIDH1 | |
| SCHEMBL659516 | 0.71 | CYP2C19 (0.60) | CTRCALDH1A1TDP1CYP1A2CYP2C19 | |
| SCHEMBL4667060 | 0.71 | CYP2C19 (0.60) | CTRCALDH1A1TDP1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4590301-A | USING PHENOL OR DIKETONE CYCLOHEXYL COMPOUNDS | BARNES-HIND, INC. (US) | 1986-05-20 | — | — | US | claimed |
| EP-0179476-A1 | Polymerization inhibitors and polymerization-inhibited solutions of monomers | Barnes-Hind, Inc. (US) | 1986-04-30 | — | — | EP | claimed |
| US-8470932-B2 | Scalable process for synthesis of a curable wax | XEROX CORPORATION (US) | 2013-06-25 | — | — | US | disclosed |
| US-8207274-B2 | Solvent-free process for synthesis of a curable wax | XEROX CORPORATION (US) | 2012-06-26 | — | — | US | disclosed |
| US-20110247521-A1 | SCALEABLE PROCESS FOR SYNTHESIS OF A CURABLE WAX | XEROX CORPORATION (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110251334-A1 | SOLVENT-FREE PROCESS FOR SYNTHESIS OF A CURABLE WAX | XEROX CORPORATION (US) | 2011-10-13 | — | — | US | disclosed |
| US-5292873-A | Nucleic acids labeled with naphthoquinone probe | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1994-03-08 | — | — | US | disclosed |
| US-4590301-A | USING PHENOL OR DIKETONE CYCLOHEXYL COMPOUNDS | BARNES-HIND, INC. (US) | 1986-05-20 | — | — | US | disclosed |
| EP-0179476-A1 | Polymerization inhibitors and polymerization-inhibited solutions of monomers | Barnes-Hind, Inc. (US) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110247521-A1 | SCALEABLE PROCESS FOR SYNTHESIS OF A CURABLE WAX | HACL2, USP14, USP16 | MAOA 1689/4885MAOB 1884/4885CTRC 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.